Healthcare -
Biotechnology - NASDAQ - US
$ 14.25
-4.55 %
$ 2.42 B
Market Cap
-5.52
P/E
IMVT - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities IMVT - Immunovant, Inc.
-360 K
LAST VALUE
-19.05%
2 YEAR CAGR
-47.25%
5 YEAR CAGR
0.00%
10 YEAR CAGR